Dupont E - Search Results

1

Myoclonus-dystonia due to genomic deletions in the epsilon-sarcoglycan gene.

Asmus F, Salih F, Hjermind LE, Ostergaard K, Munz M, Kühn AA, Dupont E, Kupsch A, Gasser T. Asmus F, et al. Among authors: dupont e. Ann Neurol. 2005 Nov;58(5):792-7. doi: 10.1002/ana.20661. Ann Neurol. 2005. PMID: 16240355

2

A novel mutation in the epsilon-sarcoglycan gene causing myoclonus-dystonia syndrome.

Hjermind LE, Werdelin LM, Eiberg H, Krag-Olsen B, Dupont E, Sørensen SA. Hjermind LE, et al. Among authors: dupont e. Neurology. 2003 May 13;60(9):1536-9. doi: 10.1212/01.wnl.0000061480.86610.bf. Neurology. 2003. PMID: 12743249

3

Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype.

Asmus F, Hjermind LE, Dupont E, Wagenstaller J, Haberlandt E, Munz M, Strom TM, Gasser T. Asmus F, et al. Among authors: dupont e. Brain. 2007 Oct;130(Pt 10):2736-45. doi: 10.1093/brain/awm209. Brain. 2007. PMID: 17898012

4

Dopa-responsive dystonia and Tourette syndrome in a large Danish family.

Romstad A, Dupont E, Krag-Olsen B, Østergaard K, Guldberg P, Güttler F. Romstad A, et al. Among authors: dupont e. Arch Neurol. 2003 Apr;60(4):618-22. doi: 10.1001/archneur.60.4.618. Arch Neurol. 2003. PMID: 12707079

5

Low frequency of Parkin, Tyrosine Hydroxylase, and GTP Cyclohydrolase I gene mutations in a Danish population of early-onset Parkinson's Disease.

Hertz JM, Ostergaard K, Juncker I, Pedersen S, Romstad A, Møller LB, Güttler F, Dupont E. Hertz JM, et al. Among authors: dupont e. Eur J Neurol. 2006 Apr;13(4):385-90. doi: 10.1111/j.1468-1331.2006.01249.x. Eur J Neurol. 2006. PMID: 16643317

6

Cabergoline plasma concentration is increased during concomitant treatment with itraconazole.

Christensen J, Dupont E, ØStergaard K. Christensen J, et al. Among authors: dupont e. Mov Disord. 2002 Nov;17(6):1360-2. doi: 10.1002/mds.10250. Mov Disord. 2002. PMID: 12465083

7

Effects of bilateral stimulation of the subthalamic nucleus in patients with severe Parkinson's disease and motor fluctuations.

Østergaard K, Sunde N, Dupont E. Østergaard K, et al. Among authors: dupont e. Mov Disord. 2002 Jul;17(4):693-700. doi: 10.1002/mds.10188. Mov Disord. 2002. PMID: 12210858 Clinical Trial.

8

Improvement of sleep quality in patients with advanced Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

Hjort N, Østergaard K, Dupont E. Hjort N, et al. Among authors: dupont e. Mov Disord. 2004 Feb;19(2):196-9. doi: 10.1002/mds.10639. Mov Disord. 2004. PMID: 14978676

9

[Deep brain stimulation of therapy-refractory, disabling dystonia. Danish Society of Movement Disorders (Danmodis)].

Hjermind LE, Løkkegaard A, Werdelin LM, Regeur L, Jespersen B, Madsen FF, Badakhshani K, Dupont E, Sunde NA, Sørensen JC, Ostergaard K, Karlsborg M. Hjermind LE, et al. Among authors: dupont e. Ugeskr Laeger. 2005 Mar 21;167(12-13):1378. Ugeskr Laeger. 2005. PMID: 15832699 Danish. No abstract available.

10

Clozapine treatment of drug-induced psychotic symptoms in late stages of Parkinson's disease.

Ostergaard K, Dupont E. Ostergaard K, et al. Among authors: dupont e. Acta Neurol Scand. 1988 Oct;78(4):349-50. doi: 10.1111/j.1600-0404.1988.tb03668.x. Acta Neurol Scand. 1988. PMID: 3223229 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters